Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Adults 60 Through 64 Years of Age
Clinical trial NCT03313037 · COMPLETED
Trial details
- NCT number
- NCT03313037
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-10
- Primary completion
- 2018-12-10
- Enrollment
- 444
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.